Tribunal confirms business promotion expenses, rejects disallowance. MCI rules not applicable. Revenue appeal dismissed.

The Tribunal upheld the CIT(A)'s decision to delete the disallowance of Rs. 22,99,72,607/-, concluding that the expenses were incurred for business promotion and not as prohibited freebies. The MCI regulations were found to be applicable only to medical practitioners, and the CBDT Circular could not retrospectively apply to the assessment year in question. The appeal filed by the Revenue was dismissed.

---

---

Issues Involved:
1. Disallowance of expenses related to freebies given by the assessee to doctors.
2. Applicability of Medical Council of India (MCI) regulations to pharmaceutical companies.
3. Validity and retrospective applicability of CBDT Circular No. 5/2012.

Issue-wise Detailed Analysis:

1. Disallowance of Expenses Related to Freebies Given by the Assessee to Doctors:
The Revenue challenged the deletion of Rs. 22,99,72,607/- disallowed by the AO, arguing that such freebies are prohibited by MCI regulations and are not allowable under Explanation to Section 37(1) of the Income-tax Act, 1961. The assessee, a pharmaceutical company, claimed these expenses under categories like 'Customer Relationship Management expenses' (CRM), 'Key Account Management expenses' (KAM), gift articles, and cost of samples. The AO disallowed these expenses, citing the CBDT Circular No. 5/2012 and the MCI regulations prohibiting medical practitioners from accepting gifts, travel facilities, hospitality, and monetary grants from pharmaceutical companies.

2. Applicability of Medical Council of India (MCI) Regulations to Pharmaceutical Companies:
The CIT(A) and the Tribunal both held that the MCI regulations are meant for medical practitioners and not for pharmaceutical companies. The Tribunal referenced the Delhi High Court judgment in Max Hospital vs. MCI, where it was clarified that MCI regulations apply only to medical practitioners and not to the healthcare sector industry. The Tribunal emphasized that the MCI regulations do not have jurisdiction over pharmaceutical companies, and thus, there is no violation of any law by the assessee in incurring such expenses.

3. Validity and Retrospective Applicability of CBDT Circular No. 5/2012:
The Tribunal noted that the CBDT Circular dated 01.08.2012 cannot have retrospective effect for the assessment year 2010-11. The Circular, which interprets the MCI regulations to apply to pharmaceutical companies, was deemed to have overstepped its jurisdiction. The Tribunal cited the principle that a circular imposing a new burden cannot be applied retrospectively. The Tribunal also referenced the decision in Syncom Formulations (I) Ltd., where it was held that the CBDT Circular would not apply to the assessment years 2010-11 and 2011-12.

Conclusion:
The Tribunal upheld the CIT(A)'s decision to delete the disallowance of Rs. 22,99,72,607/-, concluding that the expenses were incurred for business promotion and not as prohibited freebies. The MCI regulations were found to be applicable only to medical practitioners, and the CBDT Circular could not retrospectively apply to the assessment year in question. The appeal filed by the Revenue was dismissed.

---